A series of mononuclear ruthenium(II) complexes containing the tetradentate ligand bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane have been synthesised and their biological properties examined. In the synthesis of the [Ru( phen')(bb 7 )] 2+ complexes (where phen' = 1,10-phenanthroline and its 5-nitro-, 4,7-dimethyland 3,4,7,8-tetramethyl-derivatives), both the symmetric cis-α and non-symmetric cis-β isomers were formed. However, upon standing for a number of days (or more quickly under harsh conditions) the cis-β isomer converted to the more thermodynamically stable cis-α isomer. The minimum inhibitory concentrations ( 
Introduction
Due to a developing resistance to antimicrobial drugs, bacterial diseases are becoming a significantly greater threat to humans. Of note, the World Health Organisation has stated that antimicrobial resistance is one of the most important problems currently affecting global health, food security and development.
1 As a consequence, there is considerable interest in the development of new classes of antimicrobial agents, and while the development of new drugs based upon organic compounds continues, transition metal-based antimicrobial agents in general have been attracting attention -and ruthenium(II) complexes in particular. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] A range of ruthenium(II)
complexes have been studied, and generally have shown good activity against Gram-positive bacteria, but variable and often poor activity against Gram-negative species. [10] [11] [12] Dwyer and co-workers were the first to study the biological activity of mononuclear tris(bidentate) inert metal complexes with ligands such as 1,10-phenanthroline ( phen) and its derivatives {e.g. 3,4,7,8-tetramethyl-1,10-phenanthroline (Me 4 phen) and 5-nitro-1,10-phenanthroline (5-NO 2 phen)}. 9 More recently, a wide range of mononuclear {e.g. [Ru(2,9-Me 2 phen) 2 
(dppz)]
2+ } (2,9-Me 2 phen = 2,9-dimethyl-1,10-phenanthroline; dppz = dipyrido[3,2-a:2′,3′-c]phenazine) 10 and diand oligo-nuclear polypyridylruthenium(II) 12, 14, 15 complexes have been examined. In particular, earlier studies from our laboratories have examined the antimicrobial properties of di-, triand tetra-nuclear polypyridylruthenium(II) complexes in which the metal centres are linked by the bis[4(4′-methyl-2,2′-bipyridyl)]-1,n-alkane ligand ("bb n "; see Fig. 1 ). 14 While these oligonuclear ruthenium complexes showed excellent activity against drug-sensitive Gram-positive bacterial strains, and maintained the activity against drug-resistant strains, they exhibited relatively poor activity against some Gram-negative strains. 16 More recently, we synthesised mononuclear ruthenium complexes that contained the bb n moiety (for n = 10 and 12), but as a tetradentate ligand, 17 rather than as a ligand linking metal centres.
While the cis-α-[Ru(phen)(bb 12 3 ] 2+ against most of the bacterial strains. 17 The antimicrobial activity of the [Ru(phen)-(bb n )] 2+ complexes could be potentially improved through an increase of the lipophilicity, for example by utilising the bb 16 ligand. However, an alternative approach is to decrease the lipophilicity of the bb n chain but increase the electron density at the ruthenium centre through the incorporation of electrondonating groups on the 1,10-phenanthroline ligand. It has been established that the antimicrobial activity of the metal complexes is significantly affected by the cellular uptake, 15 which in turn is presumably sensitive to the charge on the metal centre as well as the overall lipophilicity. Consequently, the modulation of the electron density at the metal centre could provide higher uptake and greater ability to modulate the differential uptake between bacterial and eukaryotic cells. Herein, we describe the synthesis of a series of complexes involving 1,10-phenanthroline and some of its deriva- Fig. 1 The bb n ligand and the Rubb n , Rubb n -tri and Rubb n -tetra complexes.
tives -[Ru(phen′)(bb 7 )] 2+ {where phen′ = phen; 4,7-dimethyl- to 130-140°C with the bb 7 ligand in ethylene glycol: the 2+ complexes were isolated from higher-charged species using cationexchange chromatography on a SP Sephadex C-25 column with aqueous sodium chloride as the eluent, and the resulting solid products recrystallised from acetonitrile/diethyl ether. Subsequent cation-exchange chromatography on a SP Sephadex C-25 column (1 metre) with sodium toluene-4-sulfonate as the eluent realised two bands -the cis-α isomer and corresponding [Ru(phen′)(Me 2 bpy) 2 ] 2+ species as a minor product. All the complexes were characterised by microanalysis, NMR spectroscopy and high-resolution electrospray ionisation (ESI) mass spectrometry. The cis-α-[Ru(Me 4 phen)(bb 7 )] 2+ complex was also characterised by X-ray crystallography (see Table 1 and Fig. 2 ). In our recent synthetic study 17 7 ligand was examined in detail. When samples were taken from the reaction mixture during the course of the synthesis and studied by 1 H NMR, both the cis-α and cis-β isomers were unambiguously identified in COSY spectra of the reaction mixture. However, after either heating the reaction mixture to 200°C (see Fig. 4 ) or allowing the mixture of the isolated isomers stand at room temperature for several weeks, only the cis-α isomer was observed. In addition, during the purification process for the cis-α isomer for all the [Ru( phen′)(bb 7 X-ray crystallography (see Fig. S1 : ESI †). The same observations were made for reactions conducted under normal laboratory light or in the dark.
As the cis-β-[Ru(Me 4 phen)(bb 7 )] 2+ complex appeared to be less stable than the corresponding cis-α isomer, it was of interest to compare the relative energies of the isomers through DFT calculations. In addition, the differences in energies between the cis-α and cis-β isomers for the bb 7 complex were compared to those for the corresponding bb 12 complex. As shown in Table 2 (designated α-Me 4 phen-12) complexes, significant differences were observed between the corresponding cis-β isomers (designated β-Me 4 phen-7 and β-Me 4 phen-12, respectively): see Table 3 . Furthermore, the β-Me 4 phen-12 complex was determined to be 5.6 kJ mol −1 less stable than the α-Me 4 phen-12, whereas by contrast β-Me 4 phen-7 was 76.8 kJ mol −1 less stable than the α-Me 4 phen-7 isomer. It is observed that the calculated difference in the N1-Ru-N5 angle between the β-Me 4 phen-7 and β-Me 4 phen-12 species is significant (Table 3) , and this may well be the origin of the instability of the β-Me 4 phen-7 species relative to both the α-Me 4 phen-7 isomer and the β-Me 4 phen-12 analogue. However, no significant differences in the calculated Ru-N bond lengths were observed between the α-Me 4 phen-7 and β-Me 4 phen-7 isomers.
Scheme 1 Synthesis of [Ru( phen')(bb 7 )] 2+ complexes containing the bb 7 ligand.
Antimicrobial activity
The minimum inhibitory concentrations (MIC) for the ruthenium complexes against six bacterial strains (methicillin-resistant Staphylococcus aureus (MRSA) and a methicillin-sensitive strain of S. aureus, both avian pathogenic (APEC) and uropathogenic (UPEC) strains of Escherichia coli as well as a laboratory strain (E. coli MG1655), and Pseudomonas aeruginosa PAO1) were determined and the results are summarised in 
Lipophilicity (log P)
Lipophilicity is a factor that affects the biological activity of any metal complex because it is often correlated with the capacity of the drug to penetrate through the cell membrane. PAO1 were determined by measuring the concentration of the complex remaining in the culture supernatant after removing the bacteria by centrifugation. The concentration of the ruthenium complex in the supernatant was calculated from a luminescence calibration curve obtained by adding known concentrations of the ruthenium complex to a blank supernatant. As the luminescence of the ruthenium complexes varied with the different broths and supernatants for each bacterial strain, a calibration curve was determined for each complex in the supernatant of each bacterial strain. Fig. 6 shows the cellular accumulation of the ruthenium complexes against MRSA, UPEC and PAO1 at various time points. The uptake of the ruthenium complexes was greater with the Gram-positive bacteria compared with the Gram-negative strains, with PAO1 showing the lowest accumulation -consistent with the observed MIC/MBC values. In addition, while the accumulation in Gram-positive bacteria gradually increased with time for all complexes, the same result was not observed for the Gram-negative bacteria strains. Interestingly, the cellular accumulation of the cis-α-[Ru(Me 4 phen)(bb 7 . Carbon chain lengths of n = 7 and 12 were calculated for cis-α-and cis-β-[Ru(Me 4 phen)(bb n )] 2+ . being two-to four-fold higher than for the other three complexes.
Interaction with DNA
As previous studies showed that the di-, tri-and tetra-nuclear ruthenium complexes linked by the bb n ligand preferentially localise with DNA and RNA in bacterial and eukaryotic cells, 18, 19 it was of interest to examine the DNA binding affinity of the [Ru( phen′)(bb n )] 2+ complexes to DNA. The binding of the ruthenium complexes to calf-thymus (CT)-DNA was examined by UV/Vis spectroscopy and the intrinsic binding constants K to DNA calculated by a non-linear least-square method using eqn (1).
where [DNA] is the concentration of DNA in M (nucleotide); ε a is the molar absorption coefficient observed for the 1 MLCT absorption band at a given DNA concentration; ε f is the molar absorption coefficient of the free complex without DNA; ε b is the molar absorption coefficient of the complex fully bound to DNA; K is the equilibrium-binding constant in M (see Table 7 ). As the DNA binding affinities were surprisingly strong, the well-known high affinity metallointercalator complex [Ru( phen) 2 the cis-β isomer was not stable and converted predominantly to the cis-α isomer over time or in harsh conditions. It is concluded that the cis-β is a kinetic product but the cis-α is the thermodynamic product. The DFT calculations demonstrated that the cis-β complex is highly strained and considerably less stable than the corresponding cis-α isomer. While we have previously reported the antimicrobial activities of mono-and oligo-nuclear ruthenium complexes that incorporate the bb n ligand, the present study also examined the effects of substituents on the 1,10-phenanthroline ligand. The antimicrobial activities were examined in relationship to the electron-withdrawing/-donating effect of substituents on the phenanthroline ligand through the analyses of their respective cellular accumulations and DNA binding. The results clearly demonstrate the importance of both cellular accumulation and DNA binding. The cis-α-[Ru(5-NO 2 phen)-(bb 7 )] 2+ complex bound DNA with the highest affinity but displayed no antimicrobial activity because it was not taken up by the bacterial cells. Given that cis-α-[Ru(5-NO 2 phen)(bb 7 )] 2+ is slightly more lipophilic than cis-α-[Ru( phen)(bb 7 )] 2+ , the lack of uptake and antimicrobial activity of the nitro-substituted complex suggests that relatively minor charges of the charge density on the ruthenium centre play a critical role in the diffusion of the ruthenium complex across the bacterial membrane. The introduction of methyl substituents on the 1,10-phenanthroline progressively increased the cellular accumulation and antimicrobial activities of the cis-α-[Ru( phen′)-(bb 7 )] 2+ complexes, especially against Gram-negative bacteria.
All the ruthenium complexes showed better accumulation in the Gram-positive than the Gram-negative bacteria, suggesting a clear relationship between the cellular accumulation and MIC, but only to a point. The cis-α-[Ru( phen)-(bb 12 18, 19 However, the mechanism of action for kinetically-inert polypyridylruthenium(II) complexes is still a matter of debate. In addition to nucleic acid binding, a variety of studies have proposed that these ruthenium complexes can permeabilise the bacterial membrane, 26, 27 inhibit the activity of important enzymes, 28 or induce the production of reactive oxygen species (ROS) that could cause DNA damage and bacterial cell death. 29 It is likely that for each ruthenium complex a number of these potential mechanisms are simultaneously active, with the balance between the various mechanisms modulated by the specific chemical structure.
Conclusions
The mononuclear cis-α-[Ru(Me 4 phen)(bb 7 )] 2+ complex has significant potential as an antimicrobial agent. In this study, it has been shown that it is highly active against P. aeruginosa. Our results also suggest that the antimicrobial activity differences between the cis-α-[Ru( phen′)(bb 7 )] 2+ complex and the mononuclear [Ru( phen)(bb 12 )] 2+ complexes previously studied are significant in terms of the electron density imposed by substituents on the 1,10-phenanthroline ligand. As a consequence, and given that the structure can be readily modified, it is possible that ruthenium(II) complexes can be customised to particular bacteria. Our studies continue on this project: the toxicity on eukaryotic cells of [Ru( phen′)(bb n )] 2+ species will be explored and a further probe of the working mechanisms of this class of ruthenium complexes is on the way.
Experimental
Physical measurements 1 H and 13 C NMR spectra were recorded on a Varian Advance 400 MHz spectrometer at room temperature {CDCl 3 (99.8%, CIL), CD 3 CN (>99.8%, Aldrich), or CD 3 OD (>99.8%, Aldrich)}. Luminescence was measured on a Cary Eclipse Fluorescence Spectrophotometer with λ ex = 488 nm: emission spectra were collected from λ em = 500-800 nm. Absorbance (200-600 nm) was measured on a VARIAN CARY 50 Probe UV-visible spectrophotometer. Mass-spectroscopic analysis was performed by the RSC Mass-Spectrometry Facility (Research School of Chemistry, Australian National University, Canberra), and the Campbell Microanalytical Laboratory (Chemistry Department, University of Otago) performed the microanalyses.
Materials and methods
Potassium hexafluorophosphate (KPF 6 ), and 1,10-phenanthroline and its derivatives, were purchased from Aldrich and used as supplied. Amberlite IRA-402 (chloride form) anion-exchange resin and SP Sephadex C-25 cation exchanger were obtained from GE Health Care Bioscience. Cation-adjusted MuellerHinton broth (CAMHB), Mueller-Hinton Agar2 and the antibiotic gentamicin were purchased from Sigma-Aldrich (UK). LB broth was purchased from Formedium (UK). 2 (Me 2 phen)], after filtration the crude product was dissolved in a minimal volume of dichloromethane (DCM) and then loaded onto a silica gel column (230-400 mesh; 3 cm diam). The desired product and side products were gradient-eluted using 1-4% (v/v) methanol in DCM. The purity and contents of each fraction were determined by TLC (silica gel), using 5% (v/v) methanol in DCM as eluent. The purest fractions were combined and the solvent was removed in vacuo to give light yellow-green solids: yields: cis,-cis-[RuCl 2 (DMSO) 2 A solution of cis,cis-[RuCl 2 (DMSO) 2 ( phen′)] {where phen′ = phen; Me 2 phen; Me 4 phen; and 5-NO 2 phen} (0.39 mmol) and the bb 7 ligand (0.47 mmol) in N 2 -purged ethylene glycol (35 mL) was heated to 130-140°C and stirred in an N 2 atmosphere for 2 h. The reaction mixture turned from light green to bright orange during the course of the reaction. The reaction mixture was cooled to room temperature and water (10 mL) was added to the bright-orange solution, which was then loaded onto a SP Sephadex C-25 cation-exchange column (3 × 20 cm). The column was washed with water and the desired mononuclear complex was eluted with aqueous NaCl solution (0.3 M). Solid KPF 6 (ca. 5 mg) was added to the eluate and the complex was extracted into DCM (2 × 30 mL). The organic layer was washed with water (20 mL), dried over anhydrous Na 2 SO 4 and evaporated to dryness to obtain the PF 6 − salt of the complex. Single-crystal X-ray diffraction was performed at 100(2) K on the MX-1 beamline of the Australian Synchrotron (λ = 0.7107 Å). 39 Data sets were corrected for absorption using a multi-scan method, and structures were solved by direct methods using SHELXS-2014 and refined by full-matrix least squares on F 2 by SHELXL-2014, 40 interfaced through the program X-Seed. 41 In general, all non-hydrogen atoms were refined anisotropically and hydrogen atoms were included as invariants at geometrically estimated positions, unless specified otherwise. 
Special refinement details
Compound [Ru(Me 4 phen)(bb 7 )](PF 6 ) 2 crystallises with three molecules of chloroform in the unit cell, two of which are disordered over 2 positions. The disorder was modelled and both molecules were left to freely refine to give 70% and 76% occupancy for each main position.
Bacterial strains
Two Staphylococcus aureus (Gram-positive) isolates {a wild type S. aureus strain (SH 1000) and a clinical multidrug-resistant MRSA strain (USA 300 LAC JE2)}, and three Gram-negative Escherichia coli isolates {MG 1655, NCTC 12241 (APEC) and ST 131 (UPEC)} and a Pseudomonas aeruginosa strain PAO1 (WT), were used for in vitro antimicrobial studies.
MIC and MBC determination
The MIC tests were conducted by the broth micro-dilution method in duplicate as outlined in the CLSI guidelines. 42 The MBC tests were performed in duplicate according to the standard microbiological techniques protocol. 43 The bacteria were grown in LB media incubating at 37°C for overnight. After washing and suspending in CAMHB, the bacteria were plated out on Mueller-Hinton agar, grown overnight and then suspended in growth medium CAMHB. Bacterial inocula were adjusted to a turbidity equivalent to that of a 0. were recorded after 16-18 h of incubation at 37°C. Colony counts of the inocula were performed for determination of the MBC. After MIC results were noted, 10 μL from each well was plated out on Mueller-Hinton agar. MBCs were recorded after overnight incubation at 37°C, and the concentration of compounds that produced a 99.9% kill relative to the starting inoculum was recorded as the MBC.
Cellular accumulation
The cellular accumulation of the ruthenium complexes was measured by monitoring the luminescence of the complexes remaining in the supernatant of the cultures after incubation for various periods. Bacterial inocula in log phase were adjusted to a cell concentration from 1-7 × 10 7 cfu mL −1 . The cell culture (24 mL) was placed in a 250 mL conical flask and 75 μL of stock solution (2.56 mg mL −1 ) of the ruthenium complex was added to give a final concentration of 8 μg mL bacterial suspension was centrifuged (5500 rpm) at 4°C for 10 min. Supernatants (3 mL) were carefully transferred to 5 mL tubes and the phosphorescence of the remaining ruthenium complex was measured on a Cary Eclipse Fluorescence Spectrophotometer with λ ex = 488 nm. The emission spectra were collected from λ = 500-800 nm. Volumes (21, 39, 57, 75 and 93 μL) of a stock solution (320 μg mL −1 ) of each complex were added to 3 mL aliquots of the supernatant from each control bacterial suspension (untreated with drug) to acquire a fluorescence-concentration linear correlation chart for calibration.
Lipophilicity (log P) determination
The partition coefficients (log P) were measured using the shake-flask technique. Each ruthenium complex (0.1 mM) was dissolved in the water phase (Milli-Q water) and an equal volume of n-octanol was added. The two phases were mutually saturated by shaking overnight at ambient temperature and allowed to separate on standing. The concentration of the metal complex in each phase was determined spectrophotometrically at λ = 450 nm.
DNA-binding studies
Experiments were carried out in phosphate-buffered saline (PBS) at pH 7.4. The ratio of the UV absorbance of a solution of CT-DNA at λ = 260 and 280 nm was greater than 1.8, thus indicating that the CT-DNA was sufficiently free from protein. 
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